FIGURE 9.
Synthesis of UCCy@Gel for acute MI prevention (dark phase) and therapy (light phase): the UCCy@Gel consumes oxygen via respiration to generate a hypoxic microenvironment, resulting in the upregulation of HSP70, which enhanced the tolerance of CMs for MI (left); Under 980 nm NIR irradiation, the UCCy@Gel releases photosynthetic oxygen through UCL to inhibit macrophage M1 polarization and downregulated proinflammatory cytokines IL-6 and TNF-α to repair myocardial injury (right) (Liu Y. et al., 2022).